XCS-11® Stabilized Chlorine Dioxide 

Give your customers the benefit of XCS-11® from Kemin, the ingredient on the market that neutralizes the bad breath caused by volatile sulfur compounds rather than simply masking it. Including XCS-11 in your formulations will give your customers a fresh, long-lasting clean-mouth feeling that will set your product apart.  

Benefits that are a Breath of Fresh Air

Include XCS-11 stabilized chlorine dioxide solution in your formulation to deliver benefits that end users will notice:

  • Promotes Oral Health and Hygiene
  • Fast-Acting Cure for Bad Breath
    • Blocks compounds causing bad breath
    • Targets the root causes of bad breath
  • Biofilm Control
    • Breaks up biofilms in the mouth
    • Decreases tongue coating
    • Tarter control above the gumline
    • Protects teeth and gums
  • Clean Mouth Feeling and Fresh Breath

Available in Two Strengths

This powerful Stabilized Chlorine Dioxide product is available in two distinct concentrations to support your formulation needs. XCS-11 is a 2%* concentration and XCS-11 Pro is a 5% concentration. Typical use of XCS-11 is a target concentration of 0.1-0.3% stabilized chlorine dioxide. 

*available chlorine dioxide

Applications for XCS-11® and XCS-11® Pro include: 

  • Oral care products
  • Mouthwash
  • Toothpaste
  • Breath sprays

Ready to Set Your Product Apart?

Complete the form, and a Kemin representative will get in touch soon.

These statements have not been evaluated by the US Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.

The information on this webpage is a business-to-business information and not intended for the final consumer. Certain statements may not be applicable in all geographical regions. Product labeling and associated claims differs based upon government requirements and country or region specific information should also be considered when labeling or advertising to final consumers.

This web page and its associated brochures and other documents do not constitute or provide scientific or medical advice, diagnosis, or treatment and are distributed without warranty of any kind, either expressly or implied. This web page, its title or contents and associated brochures and other documents do not in any way make recommendations for health or marketing claims by the reader. Country and region specific regulations should be considered in this regard. Each claim or statement about the effectiveness of Kemin products and/or each claim or statement comparing the effectiveness of Kemin products to the effectiveness of other products is expressly limited to the United States, unless otherwise disclosed on the Kemin websites.

 

References:

  1. Shinada et al Trials. 2008 Dec 9;9:71. doi: 10.1186/1745-6215-9-71.
  2. Shinada et Trials . 2010 Feb 12;11:14. doi: 10.1186/1745-6215-11-14.
  3. Pham et al.Clin Exp Dent Res 2018 Oct 23;4(5):206-215. doi: 10.1002/cre2.131.
  4. Siddeshappa Indian J Dent Res . Jan-Feb 2018;29(1):34-40. doi: 10.4103/ijdr.IJDR_391_16.
  5. Aung et al Trials. 2015 Jan 27;16:31. doi: 10.1186/s13063-015-0549-9.
  6. Yadav et al. J Clin Diagn Res . 2015 Sep;9(9):ZC69-74. doi: 10.7860/JCDR/2015/14587.6510.
  7. Yeturu et al J Oral Biol Craniofac Res. 2016 Jan-Apr; 6(1): 54–58.
  8. Mani et al 1.Int J Experiment Dent Sci, 1(2), pp.118-119.
  9. Drake et al Journal of Clinical Dentistry, 22(1), p.1.
  10. Peruzzo et al Brazilian Oral Research, 21, pp.70-74.
  11. Bestari et al In Journal of Physics: Conference Series (Vol. 884, No. 1, p. 012136). IOP Publishing.
  12. Grootveld et al World J Oral Health Dent. 2018;1(1):003.
  13. Kandwald et al Int. J. Dent. Health Sci, 1(1), pp.24-33.
  14. Lee et al American Journal of Dentistry, 31(6), pp.309-312.
  15. Kémeri et al Current pharmaceutical design, 26(25), pp.3015-3025.